Navigation Links
Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
Date:3/31/2008

DETROIT, March 31 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) announced today, that it has launched amifostine for injection 500mg on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma). This product has been added to Caraco's Paragraph IV marketing agreement with Sun Pharma that was signed on January 29, 2008. Sun Pharma recently received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Ethyol(R), and being the first-to-file an ANDA with a Paragraph IV certification, has a 180-day marketing exclusivity. Sun Pharma is currently involved in patent litigation with MedImmune Oncology, Inc. concerning this product in the U.S. District Court for the District of Maryland.

Amifostine is indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with ovarian cancer. This new product is bioequivalent to Ethyol(R), a registered trademark of MedImmune Oncology, Inc. Ethyol(R) had U.S. sales of approximately $80 million for the 12-month period ended December 31, 2007, according to IMS Data.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
5. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...o advice patients to give up smoking may be more s...k the habit, according to a new study in the July-...orts are evidence that nurses are widely recognize...imental health effects of tobacco use," said Dr. M...
...'s disease is usually accepted as a hazard of agin...urodegenerative diseases are a consequence of agin...Biological Studies and the Scripps Research Instit...oves it is aging that is critical for diseases lik...
...nged insurgency in Jammu and Kashmir is having a s...specially women and children.// More and more wo...fessionals in the strife-torn state. Over 50 perce...o have sought help for mental disorders in the pas...
... to a study by researchers from Texas A&M Universi...cause for obesity in children.// Dr. Alex McIntos...logy with a research appointment from Texas Agricu...e rate of obesity in children is influenced to a g...
Other Medicine News:Health News:Nurses Can Play Big Role In Helping Patients Quit Smoking 2Health News:Aging Critical For Alzheimer's Disease 2Health News:Aging Critical For Alzheimer's Disease 3Health News:More People Seeking Treatment for Mental Illness in Strife-torn Kashmir 2Health News:Parental Time Influences Children’s Nutritio 2Health News:Parental Time Influences Children’s Nutritio 3Health News:Parental Time Influences Children’s Nutritio 4
(Date:9/3/2008)...- Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu (also known as Endostar) in China,announced...dy., At the request of the SFDA, Simcere initiate...e safety and therapeutic efficacy of Endu, a modif...
(Date:9/3/2008)...nal Vascular Disease Awareness Month, CHARLOTTESV...aceuticals,LLC, a clinical-stage drug-development ...t of unmet medical needs, announced today that it ...cal trial of its lead drug,candidate trans sodium ...81,on the clinicaltrials.gov Website, is investiga...
(Date:9/3/2008)...ultaq(R) (dronedarone) decreased the risk of,strok...rial flutter already adequately treat...Sept. 3 /- The results of a...dy were presented today at,the clinical trial upda...ongress 2008, in Munich, Germany. Previous results...
(Date:9/3/2008)...rms Strong Evidence Pycnogenol(R) Lowers Joint, Pa...s Following Cessation ...e/ -- According to the Center for,Disease Control ...hritis,is on the rise. A new study published in t...s Pycnogenol(R), bark extract from the French mari...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Watson Files FDA Application for Generic YAZ 28R 29 5811 1Watson Files FDA Application for Generic YAZ 28R 29 5811 2GeoVax Co Founder Dr Harriet Robinson Named 2007 AAAS Fellow 5810 1GeoVax Co Founder Dr Harriet Robinson Named 2007 AAAS Fellow 5810 2GeoVax Co Founder Dr Harriet Robinson Named 2007 AAAS Fellow 5810 3GeoVax Co Founder Dr Harriet Robinson Named 2007 AAAS Fellow 5810 4Thoratecs ITC Division Receives FDA Warning Letter 5808 1Thoratecs ITC Division Receives FDA Warning Letter 5808 2Thoratecs ITC Division Receives FDA Warning Letter 5808 3St Jude Program Reduces Weight Gain in Young African American Girls 5806 1St Jude Program Reduces Weight Gain in Young African American Girls 5806 2St Jude Program Reduces Weight Gain in Young African American Girls 5806 3
...OCKVILLE, Md., April 21, 2007-Genentech and FDA no...afety information,regarding tracheoesophageal (TE)...atients with limited-stage small cell lung,cancer ...rm phase,II clinical trial study combined chemothe...wo confirmed serious adverse events of TE,fistula ...
...AMPA, Fla., April 16, 2007 /PRNewswire/ -- Sirion ...aceutical company, announced,today that it has rec...ug Administration (FDA) for its anti-viral therapy... keratitis. The,product is currently marketed by L... Virgan(R). Sirion licensed the rights to,Virgan(R...
Other Medicine Technology:Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: